Table 2.
Antiviral peptide consensus sequences identified from our AVP database. Three conserved sequence motifs were identified from the 280 sequences composing our AVP database. Structural characteristics were determined via AlphaFold 2.1.1 predictions, seen in Figure 1. “# AVPs” column refers to the number of unique AVP sequences which contributed to the calculated consensus sequence. Peptide weight and theoretical isoelectric points were calculated from ExPASy ProtParam. Abbreviations: CS: consensus sequence ; pI: isoelectric point.
ID | AVP consensus sequences | Characteristics | Peptide size | pI | # AVPs | Related AVPs |
---|---|---|---|---|---|---|
CS1 | GLLSKLGSLAKKLLKRIVKRIKKFLRNHVVPVIAEHLVGANA | Amphipathic α-helix | 42 residues, 4630 Da | 11.8 | 100 | BMAPs, caerins, GF-17, LL-37, mucoporins, temporins, uperins |
CS2 | GVHGGGFGGGGGGFGGNNPNRCLTNGGICWRRRGPCPTKGRQIGNCGHAKVRCCKIR | Glycine-rich motif; cysteine-rich β-sheets (3 sheets) | 57 residues, 5810 Da | 10.9 | 31 | P9R, polyphemusin II, procambarin, urumin |
CS3 | RDVALRERRGGQCRGGGPCGESCFRGCCRGICYRGGCSCRYQVRPRWKVCYRNGSCPIIIGRC | Cysteine-rich β-sheets (2 sheets) | 63 residues, 7050 Da | 9.6 | 123 | Circulins, cycloviolacins, protegrins, retryocyclins, tachyplesins, siamycins |